SCHEMBL30835993

SCHEMBL30835993

CC(C)(C)OC(=O)N1CCC(C#Cc2ccc(C(F)(F)F)cc2)C1

nearest known ligand 0.48

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ GPR119 Q8TDV5 7/20 0.48
▸ MAPT P10636 1/20 0.47
▸ STS P08842 1/20 0.43
▸ TACR1 P25103 1/20 0.43
▸ TGFBR1 P36897 1/20 0.42
▸ P2RY14 Q15391 1/20 0.42
▸ HDAC4 P56524 1/20 0.41
▸ HDAC6 Q9UBN7 1/20 0.41
▸ USP30 Q70CQ3 1/20 0.41
▸ LIPE Q05469 1/20 0.41
▸ MMP13 P45452 1/20 0.41
▸ ALDH2 P05091 1/20 0.41
▸ RORC P51449 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30836020 0.93 GPR119 (0.52) GPR119MAPTSTSTGFBR1P2RY14
SCHEMBL27402837 0.89 GPR119 (0.39) GPR119MAPTTACR1TGFBR1LIPE
SCHEMBL30835966 0.87 TACR1 (0.44) GPR119MAPTSTSTACR1TGFBR1
SCHEMBL31556508 0.87 TACR1 (0.44) GPR119MAPTSTSTACR1TGFBR1
SCHEMBL30835910 0.83 MAPT (0.43) GPR119MAPTSTSTACR1TGFBR1
SCHEMBL193960 0.82 MEN1 (0.45) GPR119MAPTUSP30MMP13
SCHEMBL31556549 0.81 USP30 (0.43) GPR119MAPTSTSTACR1USP30
SCHEMBL30836036 0.81 USP30 (0.43) GPR119MAPTSTSTACR1USP30
SCHEMBL30835999 0.81 MMP13 (0.45) GPR119MAPTSTSTACR1TGFBR1
SCHEMBL30835997 0.80 GPR119 (0.47) GPR119MAPTSTSTGFBR1ALDH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4587424-A1 YAP/TAZ-TEAD ONCOPROTEINS INHIBITORS Bridgene Biosciences, Inc. (US) 2025-07-23 — — EP disclosed
CN-119894866-A YAP/TAZ-TEAD oncoprotein inhibitors 布里奇恩生物科学公司 2025-04-25 — — CN disclosed
WO-2024059317-A1 YAP/TAZ-TEAD ONCOPROTEINS INHIBITORS BRIDGENE BIOSCIENCES, INC. (US) 2024-03-21 — — WO disclosed
Send feedback